These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8684671)

  • 1. [Digoxin-like immunoreactive factors. Review of the literature].
    Ozzola G; Boncompagni L; Galastri G; Liberatori E; Marri M; Mazzei V; Patrizi L; Parca G; Piccini L; Biagi P
    Minerva Med; 1995 Nov; 86(11):475-80. PubMed ID: 8684671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-like immunoreactivity, endogenous cardiac glycoside-like factor(s) and natriuretic hormone: more than a hypothesis.
    Clerico A
    J Nucl Med Allied Sci; 1987; 31(4):341-56. PubMed ID: 2832557
    [No Abstract]   [Full Text] [Related]  

  • 3. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency.
    Clerico A; Balzan S; Del Chicca MG; Paci A; Cocci F; Bertelli A
    Drugs Exp Clin Res; 1988; 14(9):603-7. PubMed ID: 3229323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy.
    Mahon N; Mckenna WJ
    Eur Heart J; 2000 Jul; 21(13):1034-6. PubMed ID: 10843817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy.
    Hayashi T; Ijiri Y; Toko H; Shimomura H; Okabe M; Terasaki F; Kitaura Y; Kawamura K
    Eur Heart J; 2000 Feb; 21(4):296-305. PubMed ID: 10653677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digitalis-like factor response to hyperinsulinemia in human pregnancy, a model of insulin resistance.
    Seely EW; Carroll JA; Goodfriend TL; Tao QF; Graves W
    J Hum Hypertens; 2002 Dec; 16(12):851-6. PubMed ID: 12522466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the carrier protein of digoxin-like immunoreactive substance in plasma.
    Montali U; Balzan S; Ghione S
    J Hypertens Suppl; 1987 Dec; 5(5):S299-302. PubMed ID: 3481818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in apparent serum digitalis-like factor levels with different digoxin antibodies. The "immunochemical fingerprint".
    Naomi S; Graves S; Lazarus M; Williams GH; Hollenberg NK
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):795-801. PubMed ID: 1747212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The source of endogenous digitalis-like substance in normal pregnancy.
    Gao S; Chen Z; Xu Y
    Chin Med J (Engl); 1995 Dec; 108(12):932-4. PubMed ID: 8728949
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
    Baldoncini R; Ferri C; Bellini C; Desideri G; De Angelis C; Santucci A
    Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in plasma and urinary digoxin-immunoreactive like substance in normal pregnancy and pregnancy-induced hypertensive women].
    Li AQ; Zhang ZJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):133-5, 187. PubMed ID: 8354089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like immunoreactive substance and sodium-potassium-adenosine triphosphatase inhibition in normal pregnancy: a longitudinal study.
    Gilson GJ; Graves SW; Qualls CR; Curet LB
    Obstet Gynecol; 1997 May; 89(5 Pt 1):743-6. PubMed ID: 9166313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digitalis, digitalis antibodies, digitalis-like immunoreactive substances, and sodium homeostasis: a review.
    Hastreiter AR; John EG; van der Horst RL
    Clin Perinatol; 1988 Sep; 15(3):491-522. PubMed ID: 3066550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endogenous digitalis-like substances in umbilical cord blood: analytical interference or new hormones?].
    Sandouk P; Scherrmann JM; Barrier J; Ciraru-Vigneron N; Guedeney X; Bourdon R
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):737-42. PubMed ID: 3794210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.